OLMA | Olema PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$7.35
+$0.28 (+3.96%)

Olema Pharmaceuticals (OLMA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $7.35 vs 50 $8.70 / 200 $13.82
Projection
No cross projected
Test
No active test
Last cross
Death cross 11 May 2026 ยท projected 29 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $7.00 vs 50 $16.21 / 200 $10.60
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 22 Dec 2025 ยท projected 7 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $7.35 vs 50 $7.37 / 200 $10.00
Projection
No cross projected
Test
No active test
Last cross
Death cross 17 Mar 2026 ยท projected 24 bars out

Cross history

20
crosses on record since 2023
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
11 May 2026Death steepdaily29 bars outNot tested
17 Mar 2026Death4-hour24 bars outNot tested
week of 22 Dec 2025Golden moderateweekly7 bars outNot tested
11 Sep 2025Golden moderatedaily20 bars outNot tested
17 Jul 2025Golden4-hour17 bars outโ€”

About OLMA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.